Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-11-05
1995-01-31
Henley, III, Raymond J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31195
Patent
active
053859405
ABSTRACT:
A method for treatment of stroke in a patient, involving administering to the patient a nitric oxide-releasing compound. A preferred compound of the invention is L-arginine.
REFERENCES:
patent: 4152425 (1979-05-01), Dietze et al.
patent: 4764504 (1988-08-01), Johnson et al.
patent: 4954526 (1990-09-01), Keefer
patent: 4981691 (1991-01-01), Osterholm
patent: 5028627 (1991-07-01), Kilbourn et al.
patent: 5039705 (1991-08-01), Keefer et al.
patent: 5081148 (1992-01-01), Braquet et al.
patent: 5132453 (1992-07-01), Griffith
Chiacchia, K.; All About Nitric Oxide: Vital Biological Roles Revealed; Oct. 8, 1992; pp. 4-6; Focus, HMS.
Jan Koch-Weser, Drug Therapy, Dec. 24, 1981, pp. 1560-1564, N.E. Journal of Medicine.
Thompson et al., L-Arginine Increases Cerebral Blood Flow . . . , 1992, pp. 271-272, Congress of Neurological Surgeons.
Lee et al., "A Major Component of Cerebral Neurogenic Vasodilation is Mediated by Nitric Oxide", Fed. Am. Soc. Exp. Bio., 6(4): A2149 (Abstract), (1985).
Gaw et al., "Mechanism of the Endothelium-Independent Relaxation to Intraluminal Flow in a Rabbit Cerebral Artery", Fed. Am. Soc. Exp. Bio., 6(4): A2150 (Abstract), (1985).
Chen et al., "Role of Nitric Oxide in Cerebral Neurogenic Vasodilation", Fed. Am. Soc. Exp. Biol., 6(4): A1462 (Abstract), (1985).
Faraci et al., "Does Nitric Oxide Mediate Metabolic Vasodilation of the Cerebral Microcirculation?", Fed. Am. Soc. Exp. Biol., 6(4): A1462 (Conference Paper), (1985).
Iadecola et al., "Does Nitric Oxide Mediate the Cerebrovasodilation Elicited by Hypercania?", Fed. Am. Soc. Exp. Biol., 6(4): A1462 (Conference Paper), (1985).
Rosenblum, "Endothelium-Dependent L-Arg- and L-NMMA-Sensitive Mechanisms Regulate Tone of Brain Microvessels", American Physio. Soc. 1396 (1990).
Rosenblum, "L-Arginine Suffusion Restores Response to Acetylcholine in Brain Arterioles with Damaged Endothelium", American Physio. Soc., 961 (1992).
Dawson et al., "Nitric Oxide Mediates Glutamate Neurotoxicity in Primary Cortical Cultures", Proc. Natl. Acad. Sci. USA, 88:6368-6371 (1991).
Roussel et al., "Effect of MK-801 on Focal Brain Infarction in Normotensive and Hypertensive Rats", Hypertension, 19:40-46 (1992).
Nowicki et al., "Nitric Oxide Mediates Neuronal Death After Focal Cerebral Ischemia in the Mouse", Eur. J. Pharm., 204:339-340 (1991).
Adachi et al., "Niric Oxide (NO) is Involved in Increased Cerebral Cortical Blood Flow Following Stimulation of the Nucleus Basalis of Meynert in Anesthetized Rats", Neuroscience Ltrs., 139:201-204 (1992).
Stuehr et al., "Activated Murine Macophages Secrete a Metabolite of Arginine with the Bioactivity . . . ", J. Exp. Med., 169:1011-1020 (1989).
Sakuma et al., "Identification of Arginine as a Precursor of Endothelium-Derived Relaxing Factor", Proc. Natl. Acad. Sci. USA, 85:8664-8667 (1988).
Sloan, "Thrombolysis and Stroke", Arch Neurol., 44:748 (1987).
The Merck Manual, pp. 1330-1331, 1982.
Remington's Pharmaceutical Sciences, p. 822, 1985.
Stier et al., Dialoge Computer Data Base, Medline File, Abst. #91356323, only, of Brain Res, 549(2):354-6, May 1991.
Merck Manual, pp. 1327-1329, 1982.
Snyder, "Nitric Oxide & Neurons", Current Opinion in Neurobiology 2:323-327, 1992.
Henley III Raymond J.
The General Hospital Corporation
LandOfFree
Treatment of stroke with nitric-oxide releasing compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of stroke with nitric-oxide releasing compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of stroke with nitric-oxide releasing compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102579